These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 10626062)
1. Angiotensin II in human veins: development of rapid desensitization and effect of indomethacin. Harada K; Ohmori M; Kitoh Y; Sugimoto K; Fujimura A Clin Exp Pharmacol Physiol; 1999 Dec; 26(12):959-63. PubMed ID: 10626062 [TBL] [Abstract][Full Text] [Related]
2. Local nitric oxide release does not affect tachyphylaxis to angiotensin II in dorsal hand veins in man in the presence of prostaglandin synthesis inhibition. de Haas SL; Wilkinson IB; Boyd JL; Webb DJ Br J Clin Pharmacol; 2002 Feb; 53(2):193-5. PubMed ID: 11851644 [TBL] [Abstract][Full Text] [Related]
3. Vasoconstricting effect of angiotensin II in human hand veins: influence of aging, diabetes mellitus and hypertension. Harada K; Ohmori M; Fujimura A Hypertens Res; 2002 Sep; 25(5):683-8. PubMed ID: 12452319 [TBL] [Abstract][Full Text] [Related]
4. Vasoconstrictor effect of the angiotensin-converting enzyme-resistant, chymase-specific substrate [Pro(11)(D)-Ala(12)] angiotensin I in human dorsal hand veins: in vivo demonstration of non-ace production of angiotensin II in humans. McDonald JE; Padmanabhan N; Petrie MC; Hillier C; Connell JM; McMurray JJ Circulation; 2001 Oct; 104(15):1805-8. PubMed ID: 11591618 [TBL] [Abstract][Full Text] [Related]
5. Effects of systemic endothelin A receptor antagonism in various vascular beds in men: in vivo interactions of the major blood pressure-regulating systems and associations with the GNB3 C825T polymorphism. Mitchell A; Lückebergfeld B; Bührmann S; Rushentsova U; Nürnberger J; Siffert W; Schäfers RF; Philipp T; Wenzel RR Clin Pharmacol Ther; 2004 Nov; 76(5):396-408. PubMed ID: 15536455 [TBL] [Abstract][Full Text] [Related]
6. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat. Clayton JS; Clark KL; Johns EJ; Drew GM Br J Pharmacol; 1998 Aug; 124(7):1467-74. PubMed ID: 9723960 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin II augments sympathetically induced venoconstriction in man. Benjamin N; Collier JG; Webb DJ Clin Sci (Lond); 1988 Oct; 75(4):337-40. PubMed ID: 3197370 [TBL] [Abstract][Full Text] [Related]
8. Effects of enalaprilat on venoconstriction to norepinephrine: role of prostaglandins. Dzeka TN; Townley R; Arnold JM Cardiovasc Res; 2003 Jul; 59(1):250-6. PubMed ID: 12829196 [TBL] [Abstract][Full Text] [Related]
9. Enhanced in vivo alpha1- and alpha2-adrenoceptor-mediated venoconstriction with indomethacin in humans. Callow ID; Campisi P; Lambert ML; Feng Q; Arnold JM Am J Physiol; 1998 Sep; 275(3):H837-43. PubMed ID: 9724287 [TBL] [Abstract][Full Text] [Related]
10. Augmentation of sympathetic venoconstriction by angiotensin II in human dorsal hand veins. Webb DJ; Benjamin N; Cockcroft JR; Collier JG Am J Hypertens; 1989 Sep; 2(9):721-3. PubMed ID: 2803678 [TBL] [Abstract][Full Text] [Related]
11. Endogenous angiotensin II does not contribute to sympathetic venoconstriction in dorsal hand veins of healthy humans. Masumori S; Newby DE; Strachan FE; Boon NA; Webb DJ Clin Pharmacol Ther; 1997 Sep; 62(3):327-33. PubMed ID: 9333109 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin II-induced venoconstriction involves both AT1 and AT2 receptors and is counterbalanced by nitric oxide. Fernandes L; Loiola RA; Tostes RC; Nigro D; Fortes ZB; de Carvalho MH Peptides; 2005 Dec; 26(12):2458-63. PubMed ID: 16043265 [TBL] [Abstract][Full Text] [Related]
13. Bisoprolol attenuates noradrenaline- and phenylephrine-evoked venoconstriction in man in vivo. Abdelmawla AH; Langley RW; Szabadi E; Bradshaw CM Br J Clin Pharmacol; 1997 Jul; 44(1):61-8. PubMed ID: 9241098 [TBL] [Abstract][Full Text] [Related]
14. Influence of losartan on alpha-adrenoceptor-mediated vasoconstrictor response in humans. Harada K; Kawaguchi A; Ohmori M; Fujimura A J Cardiovasc Pharmacol; 2000 Jul; 36(1):45-9. PubMed ID: 10892659 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin II enhances insulin sensitivity in healthy volunteers under euglycemic conditions. Fliser D; Arnold U; Kohl B; Hartung R; Ritz E J Hypertens; 1993 Sep; 11(9):983-8. PubMed ID: 8254181 [TBL] [Abstract][Full Text] [Related]
16. Endothelium-dependent desensitization to angiotensin II in rabbit aorta: the mechanisms involved. Jerez S; de Bruno MP; Coviello A Can J Physiol Pharmacol; 2001 Jun; 79(6):481-9. PubMed ID: 11430585 [TBL] [Abstract][Full Text] [Related]
17. Venoconstriction by angiotensin II in the human forearm is inhibited by losartan but not by nicardipine. Baan J; Chang PC; Vermeij P; Pfaffendorf M; van Zwieten PA J Cardiovasc Pharmacol; 1998 Jan; 31(1):50-5. PubMed ID: 9456277 [TBL] [Abstract][Full Text] [Related]
18. Characterization of vascular reactivity in dorsal hand veins after oral rosiglitazone treatment in healthy subjects. Schindler C; Ferrario CM; Jatzke C; Ahner K; Brosnihan KB; Bramlage P; Maywald U; Oertel R; Boecking W; Kirch W Int J Clin Pharmacol Ther; 2008 Jan; 46(1):30-9. PubMed ID: 18218295 [TBL] [Abstract][Full Text] [Related]